When systemic wide responses were investigated, it was further observed that treatment of pancreatic cancer in vivo in mice with a combination of non-invasive RF and Gem had superior antitumor effect compared to RF or Gem alone7. This evidence concerns the gene GEM and familial pancreatic carcinoma.